(S (NP (NNP COVID-19)) (VP (VBZ has) (VP (VBN created) (NP (NP (DT a) (JJ global) (NN pandemic)) (PP (IN with) (NP (JJ high) (NN morbidity) (CC and) (NN mortality))) (PP (IN in) (NP (CD 2020)))))) (. .))
(S (NP (NP (NNP Novel) (NN coronavirus)) (PRN (-LRB- -LRB-) (NP (JJ nCoV)) (-RRB- -RRB-)) (, ,) (VP (ADVP (RB also)) (VBN known) (PP (IN as) (NP (NP (NNP Severe) (NNP Acute) (NNP Respiratory) (NNP Syndrome) (NNP Coronavirus) (CD 2)) (PRN (-LRB- -LRB-) (NP (NNP SARS-CoV2)) (-RRB- -RRB-))))) (, ,)) (VP (VBZ is) (ADJP (JJ responsible) (PP (IN for) (NP (DT this) (JJ deadly) (NN disease))))) (. .))
(S (NP (NP (NP (NNP International) (NNP Committee)) (PP (IN on) (NP (NP (NNP Taxonomy)) (PP (IN of) (NP (NNP Viruses)))))) (PRN (-LRB- -LRB-) (NP (NNP ICTV)) (-RRB- -RRB-))) (VP (VBZ has) (VP (VBN declared) (SBAR (IN that) (S (NP (NN nCoV)) (VP (VBZ is) (ADJP (ADJP (ADVP (RB highly) (RB genetically)) (JJ similar) (PP (TO to) (NP (NP (JJ SARS-CoV) (NN epidemic)) (PP (IN in) (NP (CD 2003)))))) (PRN (-LRB- -LRB-) (NP (ADJP (CD 89) (NN %)) (NN similarity)) (-RRB- -RRB-)))))))) (. .))
(S (NP (NP (JJ Limited) (NN number)) (PP (IN of) (NP (ADJP (RB clinically) (VBN validated)) (NNP Human-nCoV) (JJ protein) (NN interaction) (NNS data)))) (VP (VBZ is) (ADJP (JJ available)) (PP (IN in) (NP (DT the) (NN literature)))) (. .))
(S (PP (IN With) (NP (DT this) (NN hypothesis))) (, ,) (NP (DT the) (JJ present) (NN work)) (VP (NNS focuses) (PP (IN on) (S (VP (VBG developing) (NP (NP (DT a) (JJ computational) (NN model)) (PP (IN for) (NP (JJ nCoV-Human) (NN protein) (NN interaction) (NN network)))) (, ,) (S (VP (VBG using) (NP (DT the) (ADJP (RB experimentally) (JJ validated)) (NNP SARS-CoV-Human) (NN protein) (NNS interactions)))))))) (. .))
(S (ADVP (RB Initially)) (, ,) (NP (ADJP (JJ level-1) (CC and) (JJ level-2)) (JJ human) (NN spreader) (NNS proteins)) (VP (VBP are) (VP (VBN identified) (PP (IN in) (NP (NNP SARS-CoV-Human) (NN interaction) (NN network))) (, ,) (S (VP (VBG using) (NP (JJ Susceptible-Infected-Susceptible) (PRN (-LRB- -LRB-) (NP (NNP SIS)) (-RRB- -RRB-)) (NN model)))))) (. .))
(S (NP (DT These) (NNS proteins)) (VP (VBP are) (VP (VBN considered) (PP (IN as) (NP (NP (JJ potential) (JJ human) (NNS targets)) (PP (IN for) (NP (JJ nCoV) (NN bait) (NNS proteins))))))) (. .))
(S (NP (DT A) (ADJP (NN gene-ontology) (VBN based)) (JJ fuzzy) (NN affinity) (NN function)) (VP (VBZ has) (VP (VBN been) (VP (VBN used) (S (VP (TO to) (VP (VB construct) (NP (DT the) (JJ nCoV-Human) (NN protein) (NN interaction) (NN network)) (PP (IN at) (NP (ADJP (CD 99.98) (NN %)) (NN specificity) (NN threshold))))))))) (. .))
(S (NP (DT This)) (ADVP (RB also)) (VP (VBZ identifies) (NP (NP (DT the) (JJ level-1) (JJ human) (NNS spreaders)) (PP (IN for) (NP (NNP COVID-19))) (PP (IN in) (NP (JJ human) (NN protein-interaction) (NN network))))) (. .))
(S (NP (JJ Level-2) (JJ human) (NNS spreaders)) (VP (VBP are) (ADVP (RB subsequently)) (VP (VBN identified) (S (VP (VBG using) (NP (DT the) (NNP SIS) (NN model)))))) (. .))
(S (NP (DT The) (JJ derived) (NN host-pathogen) (NN interaction) (NN network)) (VP (VBZ is) (ADVP (RB finally)) (VP (VBN validated) (S (VP (VBG using) (NP (NP (CD 7) (JJ potential) (NNP FDA) (VBD listed) (NNS drugs)) (PP (IN for) (NP (NNP COVID-19)))))) (PP (IN with) (NP (NP (JJ significant) (NN overlap)) (PP (IN between) (NP (NP (DT the) (VBN known) (NN drug) (NN target) (NNS proteins)) (CC and) (NP (DT the) (JJ identified) (NN spreader) (NNS proteins)))))))) (. .))
